Stoke Therapeutics, Inc.

NASDAQ:STOK

11.68 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Operating Activities:
Net Income -26.43-25.695-26.374-26.958-24.542-30.654-22.545-25.655-26.111-24.652-24.649-24.448-22.597-21.967-16.793-14.561-13.684-12.959-11.039-10.16-8.604-7.819-5.742-4.282-3.317-3.01-1.912
Depreciation & Amortization 0.541.111.1131.2150.6370.6110.5970.6090.3880.3020.2470.2350.2540.2490.2360.2370.2340.2240.1930.1390.1260.1050.080.0750.0640.0430.032
Deferred Income Tax 000-9.637-0.121-0.146000000.0570.0490.0370.0290000.0031.1050000000
Stock Based Compensation 7.4947.4275.416.0586.5526.765.8875.795.9266.1634.9754.6864.6144.4522.6981.581.7851.6490.7540.7120.7310.2980.1810.1190.040.0770.004
Change In Working Capital -3.243-0.03-4.691-0.875-0.3511.073-5.877-3.509-2.693-2.08151.3062.8262.6761.121-6.5771.5470.531.183-0.935-0.892-0.3011.142-1.0540.5630.1720.471-0.113
Accounts Receivables 000000000000000000000000000
Change In Inventory 000000000000000000000000000
Change In Accounts Payables -0.7493.577-1.919-1.1492.017-4.4270.351-0.633-1.3460.754-3.4432.8972.4482.344-5.4995.20300-0.0110.8910000000
Other Working Capital -2.494-3.607-2.7720.274-2.3685.5-6.228-2.876-1.347-2.83554.749-0.0712.6761.121-1.078-3.6560.531.183-0.924-1.783-0.3011.142-1.0540.5630.1720.471-0.113
Other Non Cash Items 0.0245.7819.5319.5480.5630.5560.5820.3920.4340.340.6120.3860.3220.2770.2710.2660.2620.2570.253-1.1051.5571.360.0030.010.4360.575-0.173
Operating Cash Flow -21.615-17.477-24.566-20.649-17.262-21.8-21.356-22.373-22.056-19.92832.491-16.258-14.682-15.831-20.136-10.931-10.873-9.646-10.771-10.201-8.048-6.274-6.532-3.515-3.041-2.419-1.989
Investing Activities:
Investments In Property Plant And Equipment -0.103-0.046-0.012-0.229-0.383-0.839-0.165-0.409-2.03-0.682-0.841-0.203-0.273-0.52-0.204-0.09-0.269-0.081-0.61-0.568-0.583-0.392-0.092-0.093-0.516-0.3-0.026
Acquisitions Net 0000000-45.344-69.29445.344070.438000000000000000
Purchases Of Investments -49.901-88.232000004.87-9.706-52.543-143.941-82.235-4.991-82.2350000000000000
Sales Maturities Of Investments 20010151524.31253.2518.0297953.371912000000000000000
Other Investing Activites 0-88.23210151524.31253.2545.34469.294-45.344-134.94111.797-4.991-82.23500000-0.001000.0020.01000
Investing Cash Flow -30.004-88.2789.98814.77114.61723.47353.08522.4967.2640.146-135.78211.797-5.264-82.755-0.204-0.09-0.269-0.081-0.61-0.569-0.583-0.392-0.09-0.083-0.516-0.3-0.026
Financing Activities:
Debt Repayment 000000000000000000-0.001000-0.0010000
Common Stock Issued 7.656119.8841.2997.3380.5620.04844.7430.0420.4343.09942.2450.7770.4080.1590.546105.39800000151.8380.0740.0190-0.0080.008
Common Stock Repurchased 000000000000000000000000000
Dividends Paid 000000000000000000000000000
Other Financing Activities 0.5030.7660.4180.0050.5620.0480.3110.0430.4340.3260.2620.1710.4080.1590.5461.470.6730.3690.1990.192-1-1.2-0.14189.7613.3780.07112.411
Financing Cash Flow 8.159120.651.7177.3430.5620.04845.0540.0430.4343.42542.5070.1710.4080.1590.546106.8680.6730.3690.1980.192-1150.638-0.06889.77913.3780.06312.419
Other Information:
Effect Of Forex Changes On Cash 0000000000016.25800000000000-0.00100.0010
Net Change In Cash -42.96614.97-12.8611.465-2.0831.72176.7830.1645.642-16.357-60.784-4.29-19.538-98.427-19.79495.847-10.469-9.358-11.183-10.578-9.631143.972-6.6986.189.821-2.65510.404
Cash At End Of Period 150.585193.551178.581191.442190.546192.629190.908114.125113.96568.32384.68145.464149.754169.292267.719287.513191.666202.135211.493222.676233.254242.88598.913105.60319.4239.60212.257